PRMT5, A NOVEL EPIGENETIC TARGET IN LUNG CANCERS

被引：0
|
作者：
Otterson, Gregory A. [1 ]
Wu, Xin [1 ]
Welliver, Meng [2 ]
Sharma, Smita [2 ]
Shilo, Konstantin [3 ]
机构：
[1] Ohio State Univ, Div Med Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Columbus, OH 43210 USA
[3] Ohio State Univ, Canc Ctr, Columbus, OH 43210 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
PRMT5; epigenetics;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.02-016
引用
收藏
页码：S757 / S758
页数：2
相关论文
共 50 条
  • [1] PRMT5, a Novel Epigenetic Target in Lung Cancers
    Otterson, G. A.
    Wu, X.
    Welliver, M.
    Sharma, S.
    Shilo, K.
    Hitchcock, C.
    Li, C.
    Baiocchi, R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 171 - 171
  • [2] PRMT5 inhibitors as novel treatment for cancers
    Falk, Hendrik
    Foitzik, Richard C.
    Allan, Elizabeth
    deSilva, Melanie
    Yang, Hong
    Bozikis, Ylva E.
    Nikac, Marica
    Walker, Scott R.
    Camerino, Michelle A.
    Morrow, Ben J.
    Stupple, Alexandra E.
    Lagiakos, Rachel
    Pinson, Jo-Anne
    Lessene, Romina
    Kersten, Wilhelmus J. A.
    Ganame, Danny G.
    Holmes, Ian P.
    Lunniss, Gill E.
    Chung, Matthew
    Hermans, Stefan J.
    Parker, Michael W.
    Thistlethwaite, Alison
    White, Karen
    Charman, Susan A.
    Monahan, Brendon J.
    Pilling, Patricia
    Grusovin, Julian
    Peat, Thomas S.
    Sonderegger, Stefan
    Toulmin, Emma
    Jane, Stephen M.
    Curtis, David J.
    Stupple, Paul A.
    Street, Ian P.
    CANCER RESEARCH, 2015, 75
  • [3] PRMT5 as a therapeutic target in MTAP-deleted cancers
    Wilson, Frederick H.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (10)
  • [4] Exploiting PRMT5, a metabolic and epigenetic regulator, as a novel therapeutic target in mantle cell lymphoma
    Yao, Yixin
    Li, Lingzhi
    Zhang, Liang
    Zhang, Shaojun
    Guo, Hui
    Zhang, Hui
    Badillo, Maria
    Chen, Zhihong
    Hartig, Kimberly
    Jain, Preetesh
    Nomie, Krystle
    Wang, Linghua
    Wang, Michael
    CANCER RESEARCH, 2020, 80 (16)
  • [5] PRMT5 is a therapeutic target in choroidal neovascularization
    Muniyandi, Anbukkarasi
    Martin, Matthew
    Sishtla, Kamakshi
    Motolani, Aishat
    Sun, Mengyao
    Jensen, Nathan R.
    Qi, Xiaoping
    Boulton, Michael E.
    Prabhu, Lakshmi
    Lu, Tao
    Corson, Timothy W.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [6] Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
    Elurbide, Jasmin
    Colyn, Leticia
    Latasa, Maria U.
    Uriarte, Iker
    Mariani, Stefano
    Lopez-Pascual, Amaya
    Valbuena, Emiliana
    Castello-Uribe, Borja
    Arnes-Benito, Robert
    Adan-Villaescusa, Elena
    Martinez-Perez, Luz A.
    Azkargorta, Mikel
    Elortza, Felix
    Wu, Hanghang
    Krawczyk, Marcin
    Schneider, Kai Markus
    Sangro, Bruno
    Aldrighetti, Luca
    Ratti, Francesca
    Gardini, Andrea Casadei
    Marin, Jose J. G.
    Amat, Irene
    Urman, Jesus M.
    Arechederra, Maria
    Luz Martinez-Chantar, Maria
    Trautwein, Christian
    Huch, Meritxell
    Javier Cubero, Francisco
    Berasain, Carmen
    Fernandez-Barrena, Maite G.
    Avila, Matias A.
    GUT, 2025, 74 (01) : 116 - 127
  • [7] IDENTIFICATION OF PRMT5 AS A THERAPEUTIC TARGET IN CHOLANGIOCARCINOMA
    Elurbide, Jasmin
    Colyn, Leticia
    Latasa, Maria Ujue
    Uriarte, Iker
    Mariani, Stefano
    Lopez-Pascual, Amaya
    Valbuena, Emiliana
    Castello-Uribe, Borja
    Benito, Robert Arnes
    Adan-Villaescusa, Elena
    Azkargorta, Mikel
    Elortza, Felix
    Wu, Hanghang
    Krawczyk, Marcin
    Schneider, Kai Markus
    Sangro, Bruno
    Aldrighetti, Luca
    Ratti, Francesca
    Casadei-Gardini, Andrea
    Marin, Jose
    Amat, Irene
    Urman, Jesus
    Arechederra, Maria
    Martinez-Chantar, Maria
    Trautwein, Christian
    Huch, Meritxell
    Cubero, Francisco Javier
    Berasain, Carmen
    Fernandez-Barrena, Maite
    Avila, Matias
    HEPATOLOGY, 2024, 80
  • [8] PRMT5 Is A New Epigenetic Regulator In Cardiovascular Disease
    Merkel, Tobias S.
    Hassel, David
    Krueger, Marcus
    Weichenhan, Dieter
    Plass, Christoph
    Backs, Johannes
    CIRCULATION RESEARCH, 2013, 113 (04)
  • [9] PRMT5: An Emerging Target for Pancreatic Adenocarcinoma
    Lee, Michael K. C.
    Grimmond, Sean M.
    McArthur, Grant A.
    Sheppard, Karen E.
    CANCERS, 2021, 13 (20)
  • [10] PRMT5 as a druggable target for glioblastoma therapy
    Banasavadi-Siddegowda, Yeshavanth Kumar
    Welker, Alessandra M.
    An, Min
    Yang, Xiaozhi
    Zhou, Wei
    Shi, Guqin
    Imitola, Jaime
    Li, Chenglong
    Hsu, Sigmund
    Wang, Jiang
    Phelps, Mitch
    Zhang, Jianying
    Beattie, Christine E.
    Baiocchi, Robert
    Kaur, Balveen
    NEURO-ONCOLOGY, 2018, 20 (06) : 753 - 763
12345